Aerosol therapy: the special needs of young children.
暂无分享,去创建一个
[1] K. Nikander,et al. Variation in pediatric aerosol delivery: importance of facemask. , 2005, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[2] H. Tiddens,et al. Aerosol delivery to young children by pMDI‐spacer: Is facemask design important? , 2005, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[3] M. Newhouse,et al. Measurement of peak inspiratory flow with in‐check dial device to simulate low‐resistance (Diskus) and high‐resistance (Turbohaler) dry powder inhalers in children with asthma , 2005, Pediatric pulmonology.
[4] H. Tiddens,et al. Effect of a facemask leak on aerosol delivery from a pMDI-spacer system. , 2004, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[5] W. Hop,et al. Determining factors of aerosol deposition for four pMDI-spacer combinations in an infant upper airway model. , 2004, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[6] H. Tiddens. Matching the device to the Patient , 2004, Pediatric pulmonology. Supplement.
[7] P. Barry,et al. A randomised crossover trial of facemask efficacy. , 2004, Archives of disease in childhood.
[8] H. Tiddens,et al. Aerosol therapy and the fighting toddler: is administration during sleep an alternative? , 2003, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[9] P. N. Souëf,et al. Distribution of technetium-99m-labelled QVARTM delivered using an AutohalerTM device in children , 2003, European Respiratory Journal.
[10] W. Hop,et al. Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model. , 2003, Chest.
[11] B. Rowe,et al. Holding chambers versus nebulisers for beta-agonist treatment of acute asthma. , 2003, The Cochrane database of systematic reviews.
[12] M. Newhouse,et al. Aerosol therapy with valved holding chambers in young children: importance of the facemask seal. , 2001, Pediatrics.
[13] W. Hop,et al. Aerosol delivery from spacers in wheezy infants: a daily life study. , 2000, The European respiratory journal.
[14] J. Wildhaber,et al. High‐percentage lung delivery in children from detergent‐treated spacers , 2000, Pediatric pulmonology.
[15] R. Iles,et al. Crying significantly reduces absorption of aerosolised drug in infants , 1999, Archives of disease in childhood.
[16] J. Wildhaber,et al. Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery. , 1999, The European respiratory journal.
[17] H. Bisgaard,et al. Flow-dependent effect of formoterol dry-powder inhaled from the Aerolizer. , 1997, The European respiratory journal.
[18] J. Wildhaber,et al. Electrostatic charge on a plastic spacer device influences the delivery of salbutamol. , 1996, The European respiratory journal.
[19] A. Tal,et al. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. , 1996, The Journal of pediatrics.
[20] R. Schultz,et al. Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI) products. , 1996, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[21] P. Barry,et al. The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler. , 1995, British journal of clinical pharmacology.
[22] P. Sly,et al. The influence of age on aerosol deposition in children with cystic fibrosis. , 1994, The European respiratory journal.
[23] A. Milner,et al. Drug delivery from jet nebulisers. , 1992, Archives of disease in childhood.
[24] A. Millar,et al. Improvement of pressurised aerosol deposition with Nebuhaler spacer device. , 1984, Thorax.